OUTCOMES OF CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS WITH 10%<= AND > 10% BCR-ABL1 (IS) TRANSCRIPT LEVELS AFTER 3 MONTHS OF GENERIC IMATINIB TREATMENT

Authors
Publication date
4 March 2021
Publisher

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    İstanbul Üniversitesi Açık Erişim Sistemi

    redirect
    oaioai:http://acikerisim.istanbul...
    Last time updated on 19/10/2022